Antibodies that neutralize human β interferon biologic activity recognize a linear epitope: Analysis by synthetic peptide mapping

Philip N. Redlich, Paul D. Hoeprich, C. Budd Colby, Sidney E. Grossberg

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The location of biologically relevant epitopes on recombinant human β interferon in which Ser-17 replaces Cys-17 (rh[Ser17]IFN-β) was evaluated by testing the immunoreactivity of antibodies against 159 sequential, overlapping octamer peptides. Three monoclonal antibodies (mAbs) that neutralize rh[Ser17]IFN-β biologic activity, designated A1, A5, and A7, bound to peptides spanning only residues 39-48, whereas nonneutralizing mAb bound less specifically at multiple sites near the amino terminus. The immunoreactivity of peptides spanning residues 40-47 that contained a series of single amino acid substitutions suggested that residues 41-43 (Pro-Glu-Glu) and 46 (Gin) are important for the binding of neutralizing mAbs. The reactivity of mAbs to larger synthetic peptides containing rh[Ser17]IFN-β sequences from residue 32 through residue 56 was evaluated. All mAbs except A7 reacted with synthetic peptides representing rh[Ser17]IFN-β residues 32-47, 40-56, and 32-56, but only mAbs A1 and A5 bound to the core peptide composed of residues 40-47. Peptide 32-56 effectively blocked the binding of mAbs A1 and A5 to rh[Ser17]IFN-β and markedly inhibited their neutralizing activity. Biologic activity of the peptides was undetectable. Rabbit antisera raised against peptides 32-47 and 40-56 recognized rh[Ser17]IFN-β but did not neutralize its antiviral activity. Thus, structure-function analysis by peptide mapping has permitted the identification of a linear epitope recognized by neutralizing antibody on a biologically active cytokine. We conclude that the region spanning residues 32-56 is of major importance in the expression of the biologic activity of human IFN-β.

Original languageEnglish (US)
Pages (from-to)4040-4044
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume88
Issue number9
StatePublished - 1991
Externally publishedYes

Fingerprint

Peptide Mapping
Interferons
Epitopes
Monoclonal Antibodies
Peptides
Antibodies
Neutralizing Antibodies
Amino Acid Substitution
Human Activities
Antiviral Agents
Immune Sera
Cytokines
Rabbits

Keywords

  • "Pepscan"
  • Monoclonal antibodies
  • Multiple peptide synthesis

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Antibodies that neutralize human β interferon biologic activity recognize a linear epitope : Analysis by synthetic peptide mapping. / Redlich, Philip N.; Hoeprich, Paul D.; Colby, C. Budd; Grossberg, Sidney E.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, No. 9, 1991, p. 4040-4044.

Research output: Contribution to journalArticle

@article{d58b6621f64b4b25848f61554e14af09,
title = "Antibodies that neutralize human β interferon biologic activity recognize a linear epitope: Analysis by synthetic peptide mapping",
abstract = "The location of biologically relevant epitopes on recombinant human β interferon in which Ser-17 replaces Cys-17 (rh[Ser17]IFN-β) was evaluated by testing the immunoreactivity of antibodies against 159 sequential, overlapping octamer peptides. Three monoclonal antibodies (mAbs) that neutralize rh[Ser17]IFN-β biologic activity, designated A1, A5, and A7, bound to peptides spanning only residues 39-48, whereas nonneutralizing mAb bound less specifically at multiple sites near the amino terminus. The immunoreactivity of peptides spanning residues 40-47 that contained a series of single amino acid substitutions suggested that residues 41-43 (Pro-Glu-Glu) and 46 (Gin) are important for the binding of neutralizing mAbs. The reactivity of mAbs to larger synthetic peptides containing rh[Ser17]IFN-β sequences from residue 32 through residue 56 was evaluated. All mAbs except A7 reacted with synthetic peptides representing rh[Ser17]IFN-β residues 32-47, 40-56, and 32-56, but only mAbs A1 and A5 bound to the core peptide composed of residues 40-47. Peptide 32-56 effectively blocked the binding of mAbs A1 and A5 to rh[Ser17]IFN-β and markedly inhibited their neutralizing activity. Biologic activity of the peptides was undetectable. Rabbit antisera raised against peptides 32-47 and 40-56 recognized rh[Ser17]IFN-β but did not neutralize its antiviral activity. Thus, structure-function analysis by peptide mapping has permitted the identification of a linear epitope recognized by neutralizing antibody on a biologically active cytokine. We conclude that the region spanning residues 32-56 is of major importance in the expression of the biologic activity of human IFN-β.",
keywords = "{"}Pepscan{"}, Monoclonal antibodies, Multiple peptide synthesis",
author = "Redlich, {Philip N.} and Hoeprich, {Paul D.} and Colby, {C. Budd} and Grossberg, {Sidney E.}",
year = "1991",
language = "English (US)",
volume = "88",
pages = "4040--4044",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "9",

}

TY - JOUR

T1 - Antibodies that neutralize human β interferon biologic activity recognize a linear epitope

T2 - Analysis by synthetic peptide mapping

AU - Redlich, Philip N.

AU - Hoeprich, Paul D.

AU - Colby, C. Budd

AU - Grossberg, Sidney E.

PY - 1991

Y1 - 1991

N2 - The location of biologically relevant epitopes on recombinant human β interferon in which Ser-17 replaces Cys-17 (rh[Ser17]IFN-β) was evaluated by testing the immunoreactivity of antibodies against 159 sequential, overlapping octamer peptides. Three monoclonal antibodies (mAbs) that neutralize rh[Ser17]IFN-β biologic activity, designated A1, A5, and A7, bound to peptides spanning only residues 39-48, whereas nonneutralizing mAb bound less specifically at multiple sites near the amino terminus. The immunoreactivity of peptides spanning residues 40-47 that contained a series of single amino acid substitutions suggested that residues 41-43 (Pro-Glu-Glu) and 46 (Gin) are important for the binding of neutralizing mAbs. The reactivity of mAbs to larger synthetic peptides containing rh[Ser17]IFN-β sequences from residue 32 through residue 56 was evaluated. All mAbs except A7 reacted with synthetic peptides representing rh[Ser17]IFN-β residues 32-47, 40-56, and 32-56, but only mAbs A1 and A5 bound to the core peptide composed of residues 40-47. Peptide 32-56 effectively blocked the binding of mAbs A1 and A5 to rh[Ser17]IFN-β and markedly inhibited their neutralizing activity. Biologic activity of the peptides was undetectable. Rabbit antisera raised against peptides 32-47 and 40-56 recognized rh[Ser17]IFN-β but did not neutralize its antiviral activity. Thus, structure-function analysis by peptide mapping has permitted the identification of a linear epitope recognized by neutralizing antibody on a biologically active cytokine. We conclude that the region spanning residues 32-56 is of major importance in the expression of the biologic activity of human IFN-β.

AB - The location of biologically relevant epitopes on recombinant human β interferon in which Ser-17 replaces Cys-17 (rh[Ser17]IFN-β) was evaluated by testing the immunoreactivity of antibodies against 159 sequential, overlapping octamer peptides. Three monoclonal antibodies (mAbs) that neutralize rh[Ser17]IFN-β biologic activity, designated A1, A5, and A7, bound to peptides spanning only residues 39-48, whereas nonneutralizing mAb bound less specifically at multiple sites near the amino terminus. The immunoreactivity of peptides spanning residues 40-47 that contained a series of single amino acid substitutions suggested that residues 41-43 (Pro-Glu-Glu) and 46 (Gin) are important for the binding of neutralizing mAbs. The reactivity of mAbs to larger synthetic peptides containing rh[Ser17]IFN-β sequences from residue 32 through residue 56 was evaluated. All mAbs except A7 reacted with synthetic peptides representing rh[Ser17]IFN-β residues 32-47, 40-56, and 32-56, but only mAbs A1 and A5 bound to the core peptide composed of residues 40-47. Peptide 32-56 effectively blocked the binding of mAbs A1 and A5 to rh[Ser17]IFN-β and markedly inhibited their neutralizing activity. Biologic activity of the peptides was undetectable. Rabbit antisera raised against peptides 32-47 and 40-56 recognized rh[Ser17]IFN-β but did not neutralize its antiviral activity. Thus, structure-function analysis by peptide mapping has permitted the identification of a linear epitope recognized by neutralizing antibody on a biologically active cytokine. We conclude that the region spanning residues 32-56 is of major importance in the expression of the biologic activity of human IFN-β.

KW - "Pepscan"

KW - Monoclonal antibodies

KW - Multiple peptide synthesis

UR - http://www.scopus.com/inward/record.url?scp=0025898683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025898683&partnerID=8YFLogxK

M3 - Article

C2 - 1708891

AN - SCOPUS:0025898683

VL - 88

SP - 4040

EP - 4044

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 9

ER -